Trending Now
Features
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
Medical Tourism
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
POPULAR NEWS
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
The Role of Immunotherapy in Lung Cancer Treatment
Dr Sanchayan Mandal, Consultant - Medical Oncology, HCG EKO Cancer Center
Lung cancer remains to be one of the most formidable challenges in oncology. Early-stage...
Biotechnology
MGM Healthcare’s Heart and Lung Transplant Team Performs an ABO-Incompatible Paediatric Heart Transplant on...
CHENNAI, August 23 , 2023 : MGM Healthcare is proud to announce the successful completion of an ABO-incompatible Paediatric Heart Transplant, crossing the blood...
The Future is Here: MASSH Hospital Ushers in a New Era of Smart Healthcare
NEW DELHI , August 29, 2023: A ground-breaking chapter in the realm of healthcare has unfolded with the official launch of Minimal Access Smart...
IT & Software Support
Financial Results
Hester Biosciences Ltd reports Net Profit of Rs. 3.56 crore and Revenues from Operations of Rs. 50.7 crore in Q1FY23
Ahmedabad, August 11, 2022: One of India's leading poultry and animal vaccine manufacturing company, Hester Biosciences Limited has...
Approvals
Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has granted marketing authorization for...
Clinical Trails
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...
Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.
Bulk Drug
Health Care
Alternative Medicine
Eye Care
Protecting Your Eyes: Understanding Conjunctivitis and Preventive Measures During Seasonal Outbreak
By Dr. Shibu Varkey MS, DO, DNB, FRCS(UK) Regional Medical Director, Maxivision Superspeciality Eye Hospital, Tiruchirapalli
Conjunctivitis or pink eye is a seasonal infection affecting...
Dr. Agarwals Eye Hospitals opens high-end eyecare facility in Chembur, its 10th in Mumbai
Mumbai, October 05, 2023: Dr. Agarwals Eye Hospitals has opened a state-of-the-art eyecare hospital in Chembur, Mumbai, at Signature Business Park. The facility, spread...
Winter care tips for Dry eyes
By Dr.Prardhana Reddy – Consultant ophthalmologist & Glaucoma Specialist MaxiVision Super Specialty Eye hospitals group Hyderabad
New Delhi, January 08, 2020: The mercury is falling...
Product News
Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO 2019 Congress
Tokyo, September 29, 2019: Eisai Co., Ltd. announced today that a series of abstracts will be presented during the European Society for Medical Oncology...
Investments
Latest News
Toyota Group Engaged in Full Production of Medical Face Shields
Toyota expands monthly production capacity to 40,000 units
Japan, April 28, 2020 : (JCN Newswire) - Toyota Motor Corporation (Toyota) and Toyota Group companies are...
Brinton Pharmaceuticals receives Series B funding from India Alternatives
Pune, June 18, 2019: India Alternatives Investment Advisors Ltd. invested up to USD 8 million for a significant minority stake in Brinton Pharmaceuticals Limited....
Dental Care
Tips to maintain oral health!
By Dr.MS Prasad, Dental Surgeon, Columbia Asia Referral Hospital Yeshwanthpur
It has been said that a person’s real happiness begins from the plate and is...
Hospital Management
Drug Discovery & Development
The Illustrated Guide to Living with Diabetes in India, a Self-management Guide for Diabetics...
Mumbai, Maharashtra, India, Monday, April 22, 2013 -- (Business Wire India) -- 'The Illustrated Guide to Living with Diabetes in India', a practical guide to self-manage diabetes was launched at Kochi on Friday, April 19, 2013 by Sir Michael Hirst, President, International Diabetes Federation (IDF) during the 5 th World Congress of DiabetesIndia. Dr. Shaukat Sadikot, President - Elect, IDF and Prof. Dr. Jean Claude Mbanya, Past-President, IDF was also present during this occasion. The book authored by The Living with Diabetes in India (LWDI), an online community for people with diabetes with over half a million members - and co-published in India by Popular Prakashan, is now available at leading book stores across India and through online retailers.